{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:08:15Z","timestamp":1777486095888,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.reuma.2016.06.004","type":"journal-article","created":{"date-parts":[[2016,8,26]],"date-time":"2016-08-26T03:48:14Z","timestamp":1472183294000},"page":"344-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Mielitis y lupus: cl\u00ednica, diagn\u00f3stico y tratamiento. Revisi\u00f3n"],"prefix":"10.1016","volume":"13","author":[{"given":"Edson Hern\u00e1n","family":"Chiganer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier Pablo","family":"Hryb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Carnero Contentti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2016.06.004_bib0125","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/WNL.59.4.499","article-title":"Proposed diagnostic criteria and nosology of acute transverse myelitis","volume":"59","year":"2002","journal-title":"Neurology."},{"key":"10.1016\/j.reuma.2016.06.004_bib0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.nrl.0000149975.39201.0b","article-title":"Diagnosis and management of acute myelopathies","volume":"11","author":"Kaplin","year":"2005","journal-title":"Neurologist."},{"key":"10.1016\/j.reuma.2016.06.004_bib0135","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reuma.2016.06.004_bib0140","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.59.2.120","article-title":"Transverse myelopathy in systemic lupus erythematosus: An analysis of 14 cases and review of the literature","volume":"59","author":"Kovacs","year":"2000","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2016.06.004_bib0145","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/0961203314547795","article-title":"Systemic lupus erythematosus-associated acute transverse myelitis: manifestations, treatments, outcomes, and prognostic factors in 20 patients","volume":"24","author":"Saison","year":"2015","journal-title":"Lupus."},{"key":"10.1016\/j.reuma.2016.06.004_bib0150","doi-asserted-by":"crossref","first-page":"616","DOI":"10.7326\/0003-4819-83-5-616","article-title":"Transverse myelopathy in systemic lupus erythematosus. Report of three cases and review of the literature","volume":"83","author":"Andrianakos","year":"1975","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.reuma.2016.06.004_bib0155","first-page":"280","article-title":"Transverse myelitis as a first manifestation of systemic lupus erythematosus or lupus-like disease: Good functional outcome and relevance of antiphospholipid antibodies","volume":"31","author":"D\u2019Cruz","year":"2004","journal-title":"J Rheumatol."},{"key":"10.1016\/j.reuma.2016.06.004_bib0160","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1002\/art.24937","article-title":"Distinct subtypes of myelitis in systemic lupus erythematosus","volume":"60","author":"Birnbaum","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reuma.2016.06.004_bib0165","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1468-1331.2010.03208.x","article-title":"Acute transverse myelitis and antiphospholipid antibodies in lupus. No evidence for anticoagulation","volume":"18","author":"Katsiari","year":"2011","journal-title":"European J Neurol."},{"key":"10.1016\/j.reuma.2016.06.004_bib0170","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.semarthrit.2008.09.002","article-title":"Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: Clinical, immunological, and radiological characteristics of 22 patients","volume":"39","author":"Espinosa","year":"2010","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.reuma.2016.06.004_bib0175","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.reuma.2016.06.004_bib0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1352458511431077","article-title":"The emerging relationship between neuromyelitis optica and systemic rheumatologic autoinmune disease","volume":"18","author":"Wingerchuck","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.reuma.2016.06.004_bib0185","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/acr.20486","article-title":"Neuromyelitis optica spectrum disorder in patients with connective tissue disease and myelitis","volume":"63","author":"Kolfenbach","year":"2011","journal-title":"Arth Care"},{"key":"10.1016\/j.reuma.2016.06.004_bib0190","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1007\/s00296-011-2053-1","article-title":"Initial presentation of acute transverse myelitis in systemic lupus erythematosus: Demographics, diagnosis, management and comparison to idiopathic cases","volume":"32","author":"Schulz","year":"2012","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.reuma.2016.06.004_bib0195","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1177\/0961203314541690","article-title":"Myelitis in systemic lupus erythematosus frequently manifests as longitudinal and sometimes occurs at low disease activity","volume":"23","author":"Li","year":"2014","journal-title":"Lupus."},{"key":"10.1016\/j.reuma.2016.06.004_bib0200","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1191\/096120301701548490","article-title":"Longitudinal myelitis associated with systemic lupus erythematosus: Clinical features and magnetic resonance imaging of six cases","volume":"10","author":"T\u00e9llez-Zenteno","year":"2001","journal-title":"Lupus."},{"key":"10.1016\/j.reuma.2016.06.004_bib0205","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/sc.2008.143","article-title":"Diagnostic workup of patients with acute transverse myelitis: Spectrum of clinical presentation, neuroimaging and laboratory findings","volume":"47","author":"Sellner","year":"2009","journal-title":"Spinal Cord."},{"key":"10.1016\/j.reuma.2016.06.004_bib0210","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/rheumatology\/keh532","article-title":"Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: Where do we stand?","volume":"44","author":"Ferreira","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.reuma.2016.06.004_bib0215","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromielytis optica and non-organ-specific autoimmunity","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch Neurol."},{"key":"10.1016\/j.reuma.2016.06.004_bib0220","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations","volume":"69","author":"Bertsias","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2016.06.004_bib0225","first-page":"CD002265","article-title":"Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus","author":"Trevisani","year":"2006","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.reuma.2016.06.004_bib0230","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2004.025528","article-title":"Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus","volume":"64","author":"Barile-Fabris","year":"2005","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2016.06.004_bib0235","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/rheumatology\/ker018","article-title":"The efficacy of repeated treatment with B-cell depletion therapy in systemic lupus erythematosus: An evaluation","volume":"50","author":"Turner-Stokes","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.reuma.2016.06.004_bib0240","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/ard.2006.057885","article-title":"Ef\ufb01 cacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system","volume":"66","author":"Tokunaga","year":"2007","journal-title":"Ann Rheum Dis."}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X1630064X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X1630064X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T00:27:54Z","timestamp":1536452874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X1630064X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1699258X1630064X"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2016.06.004","relation":{},"ISSN":["1699-258X"],"issn-type":[{"value":"1699-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mielitis y lupus: cl\u00ednica, diagn\u00f3stico y tratamiento. Revisi\u00f3n","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2016.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}